CCIA
Campbell & Co Investment Adviser’s Phibro Animal Health PAHC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.24M | Buy |
48,409
+5,987
| +14% | +$153K | 0.08% | 411 |
|
2025
Q1 | $906K | Buy |
42,422
+7,822
| +23% | +$167K | 0.07% | 471 |
|
2024
Q4 | $727K | Buy |
34,600
+665
| +2% | +$14K | 0.06% | 519 |
|
2024
Q3 | $764K | Buy |
33,935
+9,953
| +42% | +$224K | 0.06% | 541 |
|
2024
Q2 | $402K | Buy |
23,982
+7,941
| +50% | +$133K | 0.03% | 731 |
|
2024
Q1 | $207K | Buy |
16,041
+3,046
| +23% | +$39.4K | 0.02% | 1013 |
|
2023
Q4 | $150K | Buy |
+12,995
| New | +$150K | 0.01% | 1049 |
|
2023
Q2 | – | Sell |
-35,544
| Closed | -$545K | – | 1059 |
|
2023
Q1 | $545K | Buy |
35,544
+22,115
| +165% | +$339K | 0.1% | 388 |
|
2022
Q4 | $180K | Sell |
13,429
-9,748
| -42% | -$131K | 0.04% | 703 |
|
2022
Q3 | $308K | Sell |
23,177
-843
| -4% | -$11.2K | 0.07% | 469 |
|
2022
Q2 | $460K | Sell |
24,020
-5,226
| -18% | -$100K | 0.12% | 307 |
|
2022
Q1 | $583K | Buy |
29,246
+18,920
| +183% | +$377K | 0.16% | 217 |
|
2021
Q4 | $211K | Buy |
+10,326
| New | +$211K | 0.07% | 520 |
|
2021
Q3 | – | Sell |
-13,026
| Closed | -$376K | – | 723 |
|
2021
Q2 | $376K | Buy |
13,026
+3,433
| +36% | +$99.1K | 0.15% | 239 |
|
2021
Q1 | $234K | Buy |
+9,593
| New | +$234K | 0.14% | 309 |
|
2019
Q2 | – | Sell |
-10,667
| Closed | -$352K | – | 660 |
|
2019
Q1 | $352K | Buy |
10,667
+2,462
| +30% | +$81.2K | 0.17% | 223 |
|
2018
Q4 | $292K | Buy |
8,205
+1,225
| +18% | +$43.6K | 0.29% | 162 |
|
2018
Q3 | $299K | Sell |
6,980
-4,391
| -39% | -$188K | 0.2% | 221 |
|
2018
Q2 | $524K | Buy |
11,371
+1,700
| +18% | +$78.3K | 0.4% | 51 |
|
2018
Q1 | $384K | Sell |
9,671
-400
| -4% | -$15.9K | 0.32% | 102 |
|
2017
Q4 | $337K | Sell |
10,071
-3,223
| -24% | -$108K | 0.25% | 149 |
|
2017
Q3 | $493K | Buy |
13,294
+880
| +7% | +$32.6K | 0.4% | 62 |
|
2017
Q2 | $460K | Buy |
12,414
+4,286
| +53% | +$159K | 0.43% | 58 |
|
2017
Q1 | $228K | Buy |
+8,128
| New | +$228K | 0.59% | 87 |
|